{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:26:35Z","timestamp":1774621595327,"version":"3.50.1"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pyogenic liver abscess is an uncommon pediatric condition, and\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      represents a rare causative agent in otherwise healthy children. Such infections may signal an underlying inborn error of immunity. Alpha-1 antitrypsin (A1AT), encoded by the\n                      <jats:italic>SERPINA1<\/jats:italic>\n                      gene, is a serine protease inhibitor with key immunomodulatory functions. In mouse models, A1AT prevents degradation of the antimicrobial SPLUNC1 protein to enhance host defense against\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      . In humans, while A1AT variants can be associated with a generally increased risk of respiratory infection, to our knowledge no corresponding impact with respect to\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      has been reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case Description<\/jats:title>\n                    <jats:p>\n                      We report a previously healthy 14-month-old girl who developed\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      liver abscess without identifiable predisposing factors. Comprehensive immunologic evaluation was unremarkable except for whole exome sequencing revealing homozygous S allele pathogenic\n                      <jats:italic>SERPINA1<\/jats:italic>\n                      variant (c.863 A&amp;gt;T, p.E288V) known as the S allele associated with partial A1AT deficiency. The clinical presentation, microbiologic findings, and disease course suggested that defective A1AT function may have contributed to dysregulated inflammation and susceptibility to infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This case highlights a potential association between homozygosity in the pathogenic S variant of\n                      <jats:italic>SERPINA1<\/jats:italic>\n                      and susceptibility to severe\n                      <jats:italic>P. aeruginosa infection<\/jats:italic>\n                      , in this case liver abscess. While A1AT deficiency is classically associated with pulmonary and hepatic disease, the immunomodulatory role of A1AT suggests broader relevance in host defense. Early recognition of underlying\n                      <jats:italic>SERPINA1<\/jats:italic>\n                      defects in children with unusual or severe infections may inform prognosis, guide management, and prompt appropriate genetic counseling and surveillance for long-term complications.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1755963","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:33:17Z","timestamp":1774618397000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Pseudomonas liver abscess in a previously healthy child with homozygous pathogenic S allele variant of the SERPINA1 gene"],"prefix":"10.3389","volume":"17","author":[{"given":"Sanya","family":"Thomas","sequence":"first","affiliation":[{"name":"Precision Vaccines Program, Department of Pediatrics, Boston Children\u2019s Hospital","place":["Boston, MA, United States"]},{"name":"Department of Pediatrics, Harvard Medical School","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaric W.","family":"D\u2019Souza","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School","place":["Boston, MA, United States"]},{"name":"Division of Infectious Diseases, Department of Pediatrics, Boston Children\u2019s Hospital","place":["Boston, MA, United States"]},{"name":"Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musaab","family":"Alhezam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School","place":["Boston, MA, United States"]},{"name":"Division of Immunology, Department of Pediatrics, Boston Children\u2019s Hospital","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig D.","family":"Platt","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Harvard Medical School","place":["Boston, MA, United States"]},{"name":"Division of Immunology, Department of Pediatrics, Boston Children\u2019s Hospital","place":["Boston, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Department of Pediatrics, Boston Children\u2019s Hospital","place":["Boston, MA, United States"]},{"name":"Department of Pediatrics, Harvard Medical School","place":["Boston, MA, United States"]},{"name":"Global Health Initiative, Broad Institute of MIT & Harvard","place":["Cambridge, MA, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1978.02120360097021","article-title":"Solitary pyogenic liver abscess in children","volume":"132","author":"Vanni","year":"1978","journal-title":"Am J Dis Child."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5151.134186","article-title":"Community-acquired pseudomonas aeruginosa liver abscess with portal vein thrombosis in a child","volume":"4","author":"Zaki","year":"2014","journal-title":"Int J Crit Illn Inj Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S1413-8670(10)70046-5","article-title":"Pyogenic liver abscess caused by community-acquired multidrug resistance Pseudomonas aeruginosa","volume":"14","author":"Ulug","year":"2010","journal-title":"Braz J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1443297","article-title":"Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential","volume":"15","author":"Mazzuca","year":"2024","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0925-4439(01)00025-4","article-title":"Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles","volume":"1535","author":"Janciauskiene","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1309648110","article-title":"Anti-inflammatory and immunomodulatory properties of \u03b11-antitrypsin without inhibition of elastase","volume":"110","author":"Jonigk","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1165\/rcmb.2002-0258OC","article-title":"Inhibition of proteinase 3 by [alpha]1-antitrypsin in vitro predicts very fast inhibition in vivo","volume":"29","author":"Duranton","year":"2003","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nm0598-615","article-title":"Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis","volume":"4","author":"Belaaouaj","year":"1998","journal-title":"Nat Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-010-0677-3","article-title":"Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response","volume":"89","author":"Kessenbrock","year":"2011","journal-title":"J Mol Med (Berl)."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-010-0164-x","article-title":"Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo","volume":"59","author":"Subramaniyam","year":"2010","journal-title":"Inflammation Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M607976200","article-title":"Alpha1-antitrypsin, old dog, new tricks. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP","volume":"282","author":"Janciauskiene","year":"2007","journal-title":"J Biol Chem"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00341","article-title":"The multifaceted effects of alpha1-antitrypsin on neutrophil functions","volume":"9","author":"Janciauskiene","year":"2018","journal-title":"Front Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/0929867324666161118125827","article-title":"Alpha-1 antitrypsin deficiency: current perspective from genetics to diagnosis and therapeutic approaches","volume":"24","author":"Santangelo","year":"2017","journal-title":"Curr Med Chem"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2016.01.004","article-title":"Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications","volume":"589","author":"Zuo","year":"2016","journal-title":"Gene."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1513\/annalsats.201507-468kv","article-title":"Well-known and less well-known functions of alpha-1 antitrypsin. Its role in chronic obstructive pulmonary disease and other disease developments","author":"Janciauskiene","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1042\/bst0300093","article-title":"Gene regulation of the serine proteinase inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin","volume":"30","author":"Kalsheker","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2021.06.001","article-title":"Alpha1-antitrypsin deficiency: New therapies on the horizon","volume":"59","author":"Remih","year":"2021","journal-title":"Curr Opin Pharmacol"},{"key":"B18","article-title":"Alpha-1 Antitrypsin Deficiency. 2006 Oct 27 [updated 2023 Jun 1]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews\u00ae [Internet]","author":"Stoller","year":""},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13023-024-03069-1","article-title":"Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review","volume":"19","author":"Ferrarotti","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1042\/BST0391051","article-title":"Functional roles of SPLUNC1 in the innate immune response against Gram-negative bacteria","volume":"39","author":"Di","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"B21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","article-title":"The multifaceted functions of neutrophils","volume":"9","author":"Mayadas","year":"2014","journal-title":"Annu Rev Pathol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.10","article-title":"Neutrophils as protagonists and targets in chronic inflammation","volume":"17","author":"Soehnlein","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91167-s","article-title":"Aerosol alpha 1-antitrypsin treatment for cystic fibrosis","volume":"337","author":"McElvaney","year":"1991","journal-title":"Lancet."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701225744","article-title":"Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages","volume":"39","author":"Chan","year":"2007","journal-title":"Scand J Infect Dis"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.4.9807166","article-title":"Aerosolized prolastin suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection","volume":"160","author":"Cantin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201509-634KV","article-title":"The role of neutrophils in alpha-1 antitrypsin deficiency","author":"McCarthy","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00047306","article-title":"alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients","volume":"29","author":"Griese","year":"2007","journal-title":"Eur Respir J"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2013.00019","article-title":"Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells","volume":"1","author":"Pott","year":"2013","journal-title":"Front Public Heal"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141232","article-title":"Therapeutic effects of \u03b11-antitrypsin on pseudomonas aeruginosa infection in ENaC transgenic mice","volume":"10","author":"Nichols","year":"2015","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1465-9921-14-122","article-title":"\u03b11-Antitrypsin promotes SPLUNC1-mediated lung defense against Pseudomonas aeruginosa infection in mice","volume":"14","author":"Jiang","year":"2013","journal-title":"Respir Res"},{"key":"B31","first-page":"PA4195","article-title":"Alpha-1 antitrypsin genotype and Pseudomonas aeruginosa chronic airway infection in bronchiectasis patients","volume":"64","author":"Martinez","year":"2024","journal-title":"Eur Respir J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1755963\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:33:19Z","timestamp":1774618399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1755963\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":31,"alternative-id":["10.3389\/fimmu.2026.1755963"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1755963","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"article-number":"1755963"}}